Key statistics
As of last trade, Corcept Therapeutics Inc (CORT:NAQ) traded at 35.89, 25.23% above the 52 week low of 28.66 set on Feb 19, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 34.56 |
|---|---|
| High | 35.89 |
| Low | 34.34 |
| Bid | 35.83 |
| Offer | 35.90 |
| Previous close | 35.70 |
| Average volume | 3.42m |
|---|---|
| Shares outstanding | 106.37m |
| Free float | 94.02m |
| P/E (TTM) | 43.00 |
| Market cap | 3.80bn USD |
| EPS (TTM) | 0.8303 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 20:31 GMT.
More ▼
- Corcept Therapeutics Announces Fourth Quarter and Full-Year 2025 Audited Financial Results, Provides Corporate Update
- Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals
- Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results, Provide Corporate Update and Host Conference Call
- Overall Survival Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
- Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism
More ▼
